236 related articles for article (PubMed ID: 22215106)
1. Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress.
Ketola K; Hilvo M; Hyötyläinen T; Vuoristo A; Ruskeepää AL; Orešič M; Kallioniemi O; Iljin K
Br J Cancer; 2012 Jan; 106(1):99-106. PubMed ID: 22215106
[TBL] [Abstract][Full Text] [Related]
2. Monensin is a potent inducer of oxidative stress and inhibitor of androgen signaling leading to apoptosis in prostate cancer cells.
Ketola K; Vainio P; Fey V; Kallioniemi O; Iljin K
Mol Cancer Ther; 2010 Dec; 9(12):3175-85. PubMed ID: 21159605
[TBL] [Abstract][Full Text] [Related]
3. Dual targeting of androgen receptor and mTORC1 by salinomycin in prostate cancer.
Mirkheshti N; Park S; Jiang S; Cropper J; Werner SL; Song CS; Chatterjee B
Oncotarget; 2016 Sep; 7(38):62240-62254. PubMed ID: 27557496
[TBL] [Abstract][Full Text] [Related]
4. Salinomycin-induced apoptosis of human prostate cancer cells due to accumulated reactive oxygen species and mitochondrial membrane depolarization.
Kim KY; Yu SN; Lee SY; Chun SS; Choi YL; Park YM; Song CS; Chatterjee B; Ahn SC
Biochem Biophys Res Commun; 2011 Sep; 413(1):80-6. PubMed ID: 21871443
[TBL] [Abstract][Full Text] [Related]
5. Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition.
Liu C; Lou W; Armstrong C; Zhu Y; Evans CP; Gao AC
Prostate; 2015 Sep; 75(13):1341-53. PubMed ID: 25970160
[TBL] [Abstract][Full Text] [Related]
6. The synergistic anticancer effect of salinomycin combined with cabazitaxel in CD44+ prostate cancer cells by downregulating wnt, NF-κB and AKT signaling.
Erdogan S; Serttas R; Turkekul K; Dibirdik I
Mol Biol Rep; 2022 Jun; 49(6):4873-4884. PubMed ID: 35705771
[TBL] [Abstract][Full Text] [Related]
7. Salinomycin inhibits growth of pancreatic cancer and cancer cell migration by disruption of actin stress fiber integrity.
Schenk M; Aykut B; Teske C; Giese NA; Weitz J; Welsch T
Cancer Lett; 2015 Mar; 358(2):161-169. PubMed ID: 25529011
[TBL] [Abstract][Full Text] [Related]
8. Salinomycin Exerts Anticancer Effects on PC-3 Cells and PC-3-Derived Cancer Stem Cells In Vitro and In Vivo.
Zhang Y; Liu L; Li F; Wu T; Jiang H; Jiang X; Du X; Wang Y
Biomed Res Int; 2017; 2017():4101653. PubMed ID: 28676857
[TBL] [Abstract][Full Text] [Related]
9. Nanocarrier - Mediated Salinomycin Delivery Induces Apoptosis and Alters EMT Phenomenon in Prostate Adenocarcinoma.
Kanchan S; Marwaha D; Tomar B; Agrawal S; Mishra S; Kapoor R; Sushma ; Jha G; Sharma D; Bhatta RS; Mishra PR; Rath SK
AAPS PharmSciTech; 2024 May; 25(5):104. PubMed ID: 38724836
[TBL] [Abstract][Full Text] [Related]
10. Salinomycin selectively targets 'CD133+' cell subpopulations and decreases malignant traits in colorectal cancer lines.
Dong TT; Zhou HM; Wang LL; Feng B; Lv B; Zheng MH
Ann Surg Oncol; 2011 Jun; 18(6):1797-804. PubMed ID: 21267784
[TBL] [Abstract][Full Text] [Related]
11. The inhibitory effect of salinomycin on the proliferation, migration and invasion of human endometrial cancer stem-like cells.
Kusunoki S; Kato K; Tabu K; Inagaki T; Okabe H; Kaneda H; Suga S; Terao Y; Taga T; Takeda S
Gynecol Oncol; 2013 Jun; 129(3):598-605. PubMed ID: 23500085
[TBL] [Abstract][Full Text] [Related]
12. Salinomycin ameliorates oxidative hepatic damage through AMP-activated protein kinase, facilitating autophagy.
Kim KY; Lee SG; Baek SY; Lee EH; Jang EJ; Lee JH; Ahn SC; Chang JH; Oh TW; Kim SH; Ma JY; Kim SC; Park KI; Kim YW
Toxicol Appl Pharmacol; 2018 Dec; 360():141-149. PubMed ID: 30290169
[TBL] [Abstract][Full Text] [Related]
13. Salinomycin reduces growth, proliferation and metastasis of cisplatin resistant breast cancer cells via NF-kB deregulation.
Tyagi M; Patro BS
Toxicol In Vitro; 2019 Oct; 60():125-133. PubMed ID: 31077746
[TBL] [Abstract][Full Text] [Related]
14. The stem cell inhibitor salinomycin decreases colony formation potential and tumor-initiating population in docetaxel-sensitive and docetaxel-resistant prostate cancer cells.
Gruber M; Handle F; Culig Z
Prostate; 2020 Feb; 80(3):267-273. PubMed ID: 31834633
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Autophagy Promotes Salinomycin-Induced Apoptosis via Reactive Oxygen Species-Mediated PI3K/AKT/mTOR and ERK/p38 MAPK-Dependent Signaling in Human Prostate Cancer Cells.
Kim KY; Park KI; Kim SH; Yu SN; Park SG; Kim YW; Seo YK; Ma JY; Ahn SC
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28524116
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells.
Bhuiyan MM; Li Y; Banerjee S; Ahmed F; Wang Z; Ali S; Sarkar FH
Cancer Res; 2006 Oct; 66(20):10064-72. PubMed ID: 17047070
[TBL] [Abstract][Full Text] [Related]
17. Apocynin, an NADPH oxidase inhibitor, suppresses progression of prostate cancer via Rac1 dephosphorylation.
Suzuki S; Pitchakarn P; Sato S; Shirai T; Takahashi S
Exp Toxicol Pathol; 2013 Nov; 65(7-8):1035-41. PubMed ID: 23664830
[TBL] [Abstract][Full Text] [Related]
18. Salinomycin triggers endoplasmic reticulum stress through ATP2A3 upregulation in PC-3 cells.
Zhang Y; Li F; Liu L; Jiang H; Hu H; Du X; Ge X; Cao J; Wang Y
BMC Cancer; 2019 Apr; 19(1):381. PubMed ID: 31023247
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment of prostate cancer cells with salinomycin and Wnt inhibitor increases the efficacy of cabazitaxel by inducing apoptosis and decreasing cancer stem cells.
Serttas R; Erdogan S
Med Oncol; 2023 Jun; 40(7):194. PubMed ID: 37264204
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer stem cell selectivity of synthetic nanomolar-active salinomycin analogs.
Huang X; Borgström B; Kempengren S; Persson L; Hegardt C; Strand D; Oredsson S
BMC Cancer; 2016 Feb; 16():145. PubMed ID: 26906175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
